top of page
Blood Type

Blood and Transfusion Medicine

Eliminate uncertainties during handling, storing and transportation

​

Tridentify
QTA Tracer System® - Safeguarding as a Service®

QTA Tracer System® is a sensor-based, real-time temperature monitoring system that eliminates the uncertainty of temperature fluctuations on blood products throughout the cold chain, from donor to recipient. By subscribing to our service, the easy-to-use monitoring solution safeguards temperature sensitive blood, plasma, platelets and other components.

​

The QTA Tracer System® triggers an alarm notification when the shelf-life has been consumed. Tridentify's Shelf-Life management function is based on stability data for the specific blood component or product being monitored. 

​​

​​​​​QTA Tracer System® - cold chain logistic benefits

 

  • Eliminates uncertainty

  • Increases patient safety

  • Streamlines cold chain processes

  • Reduces waste

  • Saves time and money

​

Shelf-Life Calculation Chart_v2_edited.jpg

Shelf-Life Management

The Shelf-Life of a product varies depending on how the product is stored, transported and handled. 


Tridentify's QTA Tracer System®, that monitors temperature sensitive transfusion medicine, eliminates uncertainties whether the quality has been compromised or become unsuitable for use due to deterioration or loss of effectiveness.  â€‹

Below is an example from our Web Portal.

QTA Access POint Graph_Light_Move_2025-10-31.png

Did you know that one blood bag saves up to three lives?

Did you know that our transfusion medicin customers report up to 80 % less waste?

Logo

“Timely implementation of an item level tracing system for our hospital blood bank, which distributes about 13’000 RBCs per year. This helped us to replace a system where the support ended.”

OZAKIDETZA_logo.png

“Knowing the temperature of the packed red blood cells from the moment they were sent to the blood bank has allowed us to safely recover many bags of blood.”

Tridentify
QTA Tracer System® - Safeguarding as a Service®

Bloodbank.jpg

Easy-to-use

  • Easy-to-use - with effortless visual identity with feature for persons with Colour Vision Deficiencies (CVD)

  • Open API cloud solution

  • No integration of system is required                                                           

shelflife.png

Shelf-Life Management
as a standard

  • Continuous calculation of shelf-life based on stability data

  • Monitors and calculates even when there is no connectivity

  • Either event driven and/or based on specific requirements        

​
compliance-management-system.jpg

Quality & Compliance

  • Automatic release, no QA decision needed  if the product is ok

  • Real-time monitoring, tracing & geoposition reporting

  • Patented quality algorithms

  • MDD MedTech Device Class IIa

  • ISBT 128 standard

  • SoHO compliance

blood-herojpg.jpg

Patient Safety and Sustainability

  • Safeguarding blood and transfusion medicine

  • Increases patient safety and compliance

  • Reduces waste

  • Streamlines cold chain processes

  • Saves time and money

  • Saves lives                                                                           

SoHO (Substances of Human Origin)

Do you comply with SoHO?

​

Tridentify supports your compliance with applicable sections of the SoHO-requirements .
 

The current QTA Tracer System® may monitor all SoHO related temperature sensitive products and support compliance with SoHO, MDD, and MDR (late 2026).

​

The new Regulation on standards of quality and safety for SoHO (Substances of Human Origin) intended for human application will apply as from August 7, 2027.

​

Regulation (EU) 2024/1938 sets higher standards in the European Union (EU) for the safety and quality of substances of human origin (SoHO), such as blood products, tissues and cells, organs, breast milk, probiotics, creating a unified framework to make SoHO more accessible and reliable for everyone involved in healthcare.

​

The new EU rules will:

  • support the continued provision of SoHO therapies, now and in the future, based on high safety and quality standards and up-to-date technical rules

  • extend protective measures to new groups of patients, to donors and to offspring born from medically assisted reproduction

  • improve harmonisation across EU, facilitating cross-border exchange of SoHO and improving patient access to the therapies they need

  • create conditions for safe, effective and accessible innovation in a unique sector driven by public health services and voluntary and unpaid donations

  • improve crisis preparedness and resilience to safeguard access to therapies

  • implement digital-ready policies

  • contribute to the European Health Union by pooling of technical expertise and achieving economies of scale.

​​* Source: The European Commission 

bottom of page